Innovus Pharma Secures Additional Funding by Increasing Its Line of Credit With Its Chief Executive Officer to $1.5M, Provides Quarter Update and Timing of Its 10-Q Filing
06 août 2014 06h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCQB:INNV) today announced that the Company increased its Line of...
Innovus Pharma to Present at the FSXinterlinked Financial Investment Conference in Westlake Village, CA
28 juil. 2014 14h31 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, July 28, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, President & CEO...
Innovus Pharma to Exhibit Zestra(R), Its Clinically Proven Topical Product for Sexual Arousal and Desire at the 46th Annual Meeting of the American Association of Sexuality Educators Counselors & Therapists
04 juin 2014 11h16 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, June 4, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that it will exhibit Zestra®, its...
Innovus Pharma Announces the Issuance of a New Canadian Patent for Its Zestra(R) Product
19 mai 2014 06h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, May 19, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced the issuance on May 13, 2014 of its...
Innovus Pharma Announces the Beginning of Patient Enrollment in Its Post-Marketing EjectDelay(TM) Clinical Study in the Middle East
15 mai 2014 06h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, May 15, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced that patient enrollment has begun in...
Innovus Pharma Files for the Female Sexual Interest/Arousal Disorder (FSI/AD) Expanded Label Indication for Its Zestra(R) Product in Canada
13 mai 2014 06h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, May 13, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced that it filed on the 8th of May 2014...
Innovus Pharma to Exhibit Zestra(R) Its Clinically Proven Product for Female Sexual Arousal and Desire at the American Congress of Obstetricians and Gynecologists 2014 Annual Meeting in Chicago
16 avr. 2014 06h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, April 16, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that it will exhibit Zestra®,...
Innovus Pharma Announces Availability of EjectDelay(TM) for Premature Ejaculation in the United States
21 févr. 2014 06h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced the availability of its over the...
Innovus Pharma to Exhibit Zestra(R) its Clinically Proven Product for Female Sexual Arousal and Desire at the International Society for the Study of Women's Sexual Health 2014 Annual Meeting in San Diego
20 févr. 2014 10h00 HE
|
Innovus Pharmaceuticals, Inc.
SAN DIEGO, Feb. 20, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTC BB:INNV) today announced that it will exhibit Zestra®,...
Innovus Pharma Expands Management Team and Adds Chief Financial Officer
11 févr. 2014 06h15 HE
|
Innovus Pharmaceuticals, Inc.
LA JOLLA, Calif., Feb. 11, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV), today announced that Lynnette Dillen has joined the company as...